Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer CS Grob, AL Danforth, GS Chopra, M Hagerty, CR McKay, AL Halberstadt, ... Archives of general psychiatry 68 (1), 71-78, 2011 | 1527 | 2011 |
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens AL Halberstadt, MA Geyer Neuropharmacology 61 (3), 364-381, 2011 | 457 | 2011 |
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens AL Halberstadt Behavioural brain research 277, 99-120, 2015 | 398 | 2015 |
International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function NM Barnes, GP Ahern, C Becamel, J Bockaert, M Camilleri, ... Pharmacological reviews 73 (1), 310-520, 2021 | 212 | 2021 |
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement AL Halberstadt, MA Geyer Psychopharmacology 227, 727-739, 2013 | 206 | 2013 |
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species AL Halberstadt, M Chatha, AK Klein, J Wallach, SD Brandt Neuropharmacology 167, 107933, 2020 | 201 | 2020 |
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice AL Halberstadt, L Koedood, SB Powell, MA Geyer Journal of psychopharmacology 25 (11), 1548-1561, 2011 | 194 | 2011 |
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program GR Greer, CS Grob, AL Halberstadt Journal of psychoactive drugs 46 (1), 73-77, 2014 | 191 | 2014 |
5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice AL Halberstadt, I Van Der Heijden, MA Ruderman, VB Risbrough, ... Neuropsychopharmacology 34 (8), 1958-1967, 2009 | 171 | 2009 |
The phencyclidine-glutamate model of schizophrenia AL Halberstadt Clinical neuropharmacology 18 (3), 237-249, 1995 | 131 | 1995 |
Four factors underlying mouse behavior in an open field S Tanaka, JW Young, AL Halberstadt, VL Masten, MA Geyer Behavioural brain research 233 (1), 55-61, 2012 | 121 | 2012 |
Effects of the hallucinogen 2, 5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response AL Halberstadt, MA Geyer Neuropharmacology 77, 200-207, 2014 | 120 | 2014 |
Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus AL Halberstadt, CD Balaban Neuroscience 140 (3), 1067-1077, 2006 | 110 | 2006 |
Chronic pain and psychedelics: a review and proposed mechanism of action JP Castellanos, C Woolley, KA Bruno, F Zeidan, A Halberstadt, T Furnish Regional Anesthesia & Pain Medicine 45 (7), 486-494, 2020 | 108 | 2020 |
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens AL Halberstadt Neuropharmacology of New Psychoactive Substances (NPS) The Science Behind …, 2017 | 105 | 2017 |
Organization of projections from the raphe nuclei to the vestibular nuclei in rats AL Halberstadt, CD Balaban Neuroscience 120 (2), 573-594, 2003 | 105 | 2003 |
Effect of hallucinogens on unconditioned behavior AL Halberstadt, MA Geyer Behavioral neurobiology of psychedelic drugs, 159-199, 2018 | 101 | 2018 |
Investigation of the structure–activity relationships of psilocybin analogues AK Klein, M Chatha, LJ Laskowski, EI Anderson, SD Brandt, SJ Chapman, ... ACS pharmacology & translational science 4 (2), 533-542, 2020 | 96 | 2020 |
Synthesis and biological evaluation of tryptamines found in hallucinogenic mushrooms: norbaeocystin, baeocystin, norpsilocin, and aeruginascin AM Sherwood, AL Halberstadt, AK Klein, JD McCorvy, KW Kaylo, ... Journal of natural products 83 (2), 461-467, 2020 | 88 | 2020 |
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD) SD Brandt, PV Kavanagh, F Westphal, A Stratford, SP Elliott, K Hoang, ... Drug testing and analysis 8 (9), 891-902, 2016 | 88 | 2016 |